RANI is Rani Therapeutics Holdings, Inc. Class A Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $0.87. Market cap: $100M. Capital Quality Rank: 31/100 — Stagnant mediocrity.
Stock snapshot
| Price | $0.87 |
| Market cap | $100M |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 31 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -132.2% |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Distress |
About RANI
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Related non-dividend companies
Other non-dividend stocks investors research alongside RANI. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is RANI's current stock price?
RANI (Rani Therapeutics Holdings, Inc. Class A Common Stock) is currently trading at $0.87.
Does RANI pay a dividend?
RANI (Rani Therapeutics Holdings, Inc. Class A Common Stock) does not currently pay a regular dividend.
What is RANI's Capital Quality Rank?
RANI has a Capital Quality Rank of 31/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track RANI in DiviDrip
Add RANI to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search RANI and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.